An introduction to the metabolic determinants of anthracycline cardiotoxicity.
about
Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic EffectsA switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicityProtective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolismMicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024.Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cellsResveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients.Rodent models of heart failure: an updated review.Drug-induced oxidative stress and toxicity.Protective effect of oleanolic acid on oxidative injury and cellular abnormalities in doxorubicin induced cardiac toxicity in rats.Pharmacogenetics of anthracyclines.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.Rapid generation of hydrogen peroxide contributes to the complex cell death induction by the angucycline antibiotic landomycin E.Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin.The anthracyclines: when good things go bad.Chemotherapy-induced changes in cardiac capillary permeability measured by fluorescent multiple indicator dilution.Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy.Efficacy of antioxidants as a Complementary and Alternative Medicine (CAM) in combination with the chemotherapeutic agent doxorubicin.Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells.Redox control of cancer cell destruction.Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth
P2860
Q26752455-FAD11E47-A135-4B4E-9B90-21D99B32A3C6Q28477095-3467054A-884D-475F-A9C8-2E46626621DBQ28606782-AFACFDAA-A891-4EF7-91C4-77EDB80971E9Q34469794-09FF5A7D-A5E6-49EC-9303-5BE1DD942223Q35044480-C4A71309-EF8B-44E9-9C68-C29B114AFF33Q35915757-B331E61C-7F1D-4E99-AFC5-A940D22D185DQ36083507-FD143A8E-F353-4446-977A-56C908F21435Q36568908-1F84B8C8-B6AA-4F58-96E3-95D87716B7E8Q36948123-A78E05A1-F1E2-4134-9858-A397BF474A9BQ37996857-5202B10E-1098-4CAC-822D-31543DD88C63Q38037517-A3826B18-49DC-4171-8E3F-54E2640172F6Q38554358-1AEB9D01-81AB-416D-B825-F53BB4DBCFA7Q38856218-8EE0175B-D77D-4DD0-96B1-EECB0C3C6B82Q38875916-EFA55D05-7F64-456E-A180-4244F7C95E97Q40339399-8D8BEBFB-1569-486A-BBB0-D139A4B1B7DEQ40943399-736E5C64-4157-462D-A86C-0580033486B6Q42163160-8689AB27-5E73-44B4-9B44-263082E56946Q42550655-B88E9890-EC65-42B3-911E-52D78F55A8D4Q42678363-760221DB-0FAE-42A5-B6AC-EA92D830CD5EQ42831840-79A84842-4040-430F-A5A0-D35480C568A2Q48763582-0F33591E-A38A-4AB6-A6A2-AA678B689A63Q51748168-2170BE1C-B1CA-4925-8A37-75D8FDC8E484Q55518023-7AA56D6D-31B3-4553-9A2E-FE5F94C61D20Q58790268-1325D060-AAA4-43BF-B90B-4E22F22325A3
P2860
An introduction to the metabolic determinants of anthracycline cardiotoxicity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
An introduction to the metabolic determinants of anthracycline cardiotoxicity.
@en
type
label
An introduction to the metabolic determinants of anthracycline cardiotoxicity.
@en
prefLabel
An introduction to the metabolic determinants of anthracycline cardiotoxicity.
@en
P2093
P50
P1476
An introduction to the metabolic determinants of anthracycline cardiotoxicity
@en
P2093
Gaetano Cairo
Giorgio Minotti
Pierantonio Menna
Stefania Recalcati
P2888
P356
10.1007/S12012-007-0011-7
P577
2007-01-01T00:00:00Z